Poster Abstract Session:
54. HAI: MSSA, MRSA, and other Gram-Positives
Thursday, October 27, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Epidemiology and Infection Control, Adult ID

Presentations:
275
Lifting Contact Precautions for Methicillin Resistant Staphylococcus aureus (MRSA) Isolation: Effect on MRSA Infection Measures
Werner Bischoff, MD, PhD, FSHEA ; James Viviano, MS ; Gregory Bryan Russell, MS ; John Stehle Jr., PhD
Posters
  • Bischoff_MRSA_Poster_REV_1.pdf (294.6 kB)
  • 276
    Risk Factors for MRSA-VRE Coinfection Among Hospitalized Adults
    Katherine Hanslits, MPH Candidate ; Richard Evans, MS ; Maria Konja, MPH Candidate ; Mariam Akhtar, BS ; Kathryn Sutcliffe, MPH ; Jesse Kim, . ; Madiha Salim, MD ; Elizabeth Salzman, MS ; Keith Kaye, MD ; Emily T. Martin, MPH, PhD
    277
    Cessation of Contact Isolation for Endemic MRSA and VRE is Not Associated with Increased Infections
    Mark E. Rupp, MD, FIDSA, FSHEA ; Teresa Fitzgerald, RN ; Trevor Van Schooneveld, MD ; Angela Hewlett, MD, MS, FIDSA ; Ryan Clevenger, BS ; Elizabeth Lyden, MS
    278
    Geographic Cluster of Community-Acquired Methicillin Resistant Staphylococcus aureus Infections Among Pediatric Patients from Brooklyn, New York
    Jennifer Lighter-Fisher, MD ; Michael S. Phillips, MD ; Anna Stachel, MPH, CIC ; Arun Chopra, MD ; Israel Rosman, MBA ; Jason C. Fisher, MD ; Yi Li, PhD ; Richard Copin, PhD ; Rebecca Rosenberg, MD ; Bo Shopsin, MD, PhD
    Posters
  • IDWeed_Lighter.pdf (503.9 kB)
  • 279
    Characteristics of patients hospitalized for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) from 2009-2013
    Emily Mcginnis, M.P.H. ; Sue K. Cammarata, M.D. ; Ruo-Ding Tan, Ph.D. ; Matthew Barrett, Ph.D. ; Edward Tuttle, M.B.A.
    280
    Streptococcus anginosus group infections at a Tertiary Care Center: A Review.
    Tasaduq Fazili, MBBS ; Waleed Javaid, MD ; Timothy Endy, MD, MPH ; Tenzing Calden Shargnoe, MD ; Benjamin White, MD
    Posters
  • SAG Poster.jpg (1.8 MB)
  • 281
    Evaluating Provider Attitudes around Use of Contact Precautions in the Care of Patients with MRSA and VRE
    Preeti Mehrotra, MD ; David S Yassa, MD ; Graham M. Snyder, MD, SM ; Sharon B Wright, MD, MPH, FIDSA, FSHEA
    282
    Posters
  • Poster 282.jpg (798.5 kB)
  • 283
    Pharmacodynamics of Ceftriaxone and Alternatives as Out-Patient Antimicrobial Therapy for Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections
    Sheryl Zelenitsky, PharmD ; Nathan Beahm, BPS ; Robert Ariano, PharmD ; Harris Iacovides, PharmD ; George Zhanel, PhD
    284
    Efficacy of Skin and Nasal Povidone-Iodine Preparation and Iodine-containing Formulations in Treating MRSA Colonization of Ex Vivo Mucosal Tissue Model
    Marnie Peterson, PharmD, PhD ; Michele Anderson, PhD ; Laura Breshears, PhD ; Tera Nordby, BS ; Michelle Hulse Stevens, MD ; Matt Scholz, MS
    287
    Increased Risk of Incident Diabetes Mellitus 2 Years after Staphylococcus aureus Bacteremia. A Matched Cohort Study
    Marie-Louise Uhre Hansen, BM ; Nanja Gotland, BM ; Niels Mejer, MSc, PhD ; Anders Rhod Larsen, PhD ; Andreas Petersen, MSc, PhD ; Thomas Benfield, MD, DMSc
    Posters
  • ML_6_oktober_ID_WEEK.pdf (476.4 kB)
  • 288
    Risk Factors Associated with Faster Time to VRE Positivity in Acute Myeloid Leukemia Patients Undergoing Initial Intensive Induction Chemotherapy with Cytarabine and Idarubicin
    Ronald Heisel, PharmD ; Robert Sutton, PharmD ; Gerard Mascara, PharmD ; Daniel Winger, MS ; Seah Lim, MD ; David Weber, MD ; Louise-Marie Oleksiuk, PharmD
    Posters
  • IDSA RH FINAL.pdf (517.9 kB)
  • 289
    Vancomycin-Resistant Enterococcus (VRE) positive blood cultures: Results from a province-wide multi-site case series analysis in Ontario, Canada, January 2009-December 2013
    Jennie Johnstone, MD ; Cynthia Chen, MSc ; Michelle Policarpio, MSc ; Kwaku Adomako, MSc ; Laura Rosella, PhD ; Freda Lam, MPH, CPHI(C) ; Chatura Prematunge, MSc ; Emily Nadolny, MPH ; Jennifer Robertson, PhD ; Gary Garber, MD, FACP, FIDSA
    290
    Susceptibility of Nosocomial Staphylococcus aureus to Chlorhexidine After Implementation of a Hospital-wide Antiseptic Bathing Regimen
    Cole Marolf, Medical Student ; Paul D. Fey, PhD ; Roxanne Alter, MS ; Elizabeth Lyden, MS ; Mark E. Rupp, MD, FIDSA, FSHEA
    291
    The impact of healthcare-associated methicillin-resistant Staphylococccus aureus infections among US veterans on post-discharge healthcare cost and utilization outside the Department of Veterans Affairs healthcare system
    Richard E. Nelson, PhD ; Thomas Reese, PharmD ; Makoto Jones, MD, MS ; Vanessa W. Stevens, PhD ; Chuan-Fen Liu, MPH, PhD ; Matthew Samore, MD, FSHEA ; Martin Evans, MD, FIDSA, FSHEA ; Michael Rubin, MD, PhD, FIDSA
    292
    The Prevalence of an Inoculum Effect (InE) with Cefazolin (CFZ) and the Association with Certain blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus (MSSA) Isolates from Four Major Chicago Medical Centers
    Sheila Wang, PharmD, BCPS AQ-ID ; Ira Sigar, Ph.D. ; Annette Gilchrist, Ph.D. ; Balbina Plotkin, Ph.D. ; Tristan O'driscoll, Pharm.D. ; John O'donnell, BS Biochemistry ; Nathaniel Rhodes, PharmD, MSc ; Marc Scheetz, PharmD, MSc, BCPS AQ-ID ; Alan Gross, Pharm.D. ; Natasha Pettit, PharmD ; Cindy Bethel, BS ; Angella Charnot-Katsikas, MD ; John Segreti, MD, FIDSA, FSHEA ; Kamaljit Singh, MD
    293
    Using MRSA Screening Tests to Predict Methicillin Resistance in Staphylococcus Aureus Bacteremia 
    Guillaume Butler-Laporte, MDCM ; Matthew P. Cheng, MD ; Alexandre P. Cheng, BSc ; Emily Mcdonald, MDCM, MSc ; Todd C. Lee, MD, MPH
    Posters
  • IDWeek_MRSA.pdf (437.9 kB)
  • 295
    Clinical outcomes of bloodstream infections (BSI) due to Vancomycin-Resistant Enterococcus faecium (VRE)
    Rachel V. Marini, PharmD ; Ryan K. Shields, PharmD ; Lloyd Clarke, BScHons ; Cornelius J. Clancy, MD ; Minh-Hong Nguyen, MD ; J. Alexander Viehman, MD
    Posters
  • ID Week 2016 outcome..pdf (170.2 kB)
  • 296
    Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT) Result in Healthcare Cost Savings
    Robin H. Dretler, MD, FIDSA ; Quyen Luu, MD ; Richard C. Prokesch, MD, FACP, FIDSA ; Andrew H. Krinsky, MD ; H. Barry Baker, MD, FACP ; Claudia P. Schroeder, PharmD, PhD ; Lucinda J. Van Anglen, PharmD
    297
    Epidemiology of Skin and Soft Tissue Infection in Infantry Trainees at Fort Benning
    Carey Schlett, MPH ; Eugene Millar, PhD ; Jason Bennett, MD, MSPH ; Emad Elassal, MS ; Natasha Law, MA ; Sidney Dowlen, BA ; Demond Lyles, CRA ; Arile Hadley, BS ; Michael Ellis, MD
    Posters
  • 297_IDWPOSTER.pdf (46.0 kB)
  • 298
    Invasive Staphylococcus aureus Infection in Utah Children; Continued Dominance of MSSA over MRSA
    Hillary Crandall, MD, PhD ; Aurélie Kapusta, PhD ; Jarrett Killpack, BSc ; Edgar J. Hernandez, PhD ; Mandy Dickey, BSc ; Kody Nilsson, MD ; Judy a. Daly, PhD ; Krow Ampofo, MD, FIDSA, FPIDS ; Matthew a. Mulvey, PhD ; Kristina G. Hulten, PhD ; Mark Yandell, PhD ; Anne J. Blaschke, MD, PhD, FIDSA, FPIDS
    299
    Risk Factors for Recurrent Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
    Moira C. Mcnulty, MD ; Zachary Yin, BA ; Michael Z David, MD PhD
    301
    Randomized Double-Blinded Placebo-Controlled Trial to Assess the Effect of Retapamulin for Nasal Decolonization of Mupirocin-Resistant Methicillin-Resistant Staphylococcus aureus (Mup-R MRSA) Nasal Carriers
    Raveena Singh, MA ; Adrijana Gombosev, MS ; Tabitha Dutciuc, MPH ; Kaye Evans, BA ; Lena M Portillo, BS, MT(ASCP) ; Mary K Hayden, MD ; Daniel Gillen, PhD ; Ellena Peterson, PhD ; Thomas Tjoa, MPH, MS ; Chenghua Cao, MPH ; Eric Cui, BS ; Claudia Cervantes, BA ; Justin Chang, BS ; Brian Lewis, BS ; Diane Kim, BS ; Loren Miller, MD, MPH ; Susan S. Huang, MD, MPH, FIDSA, FSHEA
    302
    Nephrotoxicity and Clinical Outcomes in Patients Treated with Nafcillin or Cefazolin.
    W. Cliff Rutter, PharmD ; David S. Burgess, PharmD, FCCP
    Posters
  • CFZ NAF poster.pdf (726.4 kB)
  • 304
    Unexpected high prevalence of qacA/B and smr genes among Staphylococcus spp isolates from individuals attending a Sexually Transmitted Infections (STI) clinic.
    Alejandra Ugarte Torres, MD ; Johanna Delongchamp, MSc ; Linda Ward, MLT ; Joann Mcclure, BSc ; Kunyan Zhang, MD, PhD ; Thomas Louie, MD ; Judy Macdonald, MD ; Daniel Gregson, MD ; Angel Chu, MD ; Oscar Larios, MD ; Ron Read, MD, PhD, FRCPC ; John Conly, MD
    Posters
  • qacAB poster V2.pdf (2.7 MB)
  • 306
    Linezolid resistance in an academic center.
    Maria Reyes Angeles, MD ; Kevin Hsueh, MD
    307
    Regional and Source Variations in Vancomycin-resistant Enterococci (VRE) Rates in US Hospitals 2015
    Ravina Kullar, Pharm.D., M.P.H. ; Sanjay Merchant, PhD ; Ying P. Tabak, PhD ; C. Andrew Deryke, PharmD ; Richard S Johannes, MD, MS ; Eric M Sarpong, PhD ; Vikas Gupta, Pharm.D., BCPS
    308
    Impact of Allergy Status on Outcomes in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections (MSSA BSI)
    Spenser January, PharmD ; Rachel M Kenney, PharmD ; Michael Veve, PharmD ; Edward Zoratti, MD ; Marcus Zervos, MD ; Susan L Davis, PharmD
    Posters
  • veve_MSSA.pdf (263.5 kB)
  • 309
    Signs of Stigma and Poor Mental Health Among Carriers of MRSA
    Babette Rump, MD ; Mark G.J. De Boer, MD PhD ; Ria Reis, Prof. ; Marjan Wassenberg, MD PhD ; Jim Van Steenbergen, MD, PhD
    310
    Increased Risk of Incident Cancer after Staphylococcus aureus Bacteremia. A Matched Cohort Study.
    Nanja Gotland, BM ; Marie-Louise Uhre Hansen, BM ; Niels Mejer, MSc, PhD ; Robert Skov, MD ; Andreas Petersen, MSc, PhD ; Anders Rhod Larsen, PhD ; Thomas Benfield, MD, DMSc
    311
    Temporal-Spatial Distribution of USA300 MRSA Skin and Soft Tissue Infection among Infantry Trainees at Fort Benning
    Eugene Millar, PhD ; Carey Schlett, MPH ; Jason Bennett, MD, MSPH ; Emad Elassal, MS ; Deepika Mor, MS ; Jeffrey Lanier, MD ; Aaron Starbuck, MD ; David Tribble, MD, DrPH, FIDSA ; Michael Ellis, MD
    Posters
  • 311_IDWPOSTER.pdf (93.5 kB)
  • 312
    Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC); Measuring the Prevalence of vanA Genes in Healthcare Facilities (HCF) in Washington DC
    Jacqueline Reuben, MHS ; Nancy Donegan, MPH ; Jo Anne Nelson, DC ; Brendan Sinatro, MPH ; Morris Blaylock, Ph.D. ; Kimary Harmon, MBA, MPH
    Posters
  • 312_IDWk_vanA.pdf (880.9 kB)
  • 313
    Utilization of Methicillin Resistant Staphylococcus aureus Nares Screens for Empiric Antibiotic Therapy
    Jacqueline Burnell, MD ; Melanie Valentin-Torres, MD ; Sharon M Smith, PhD ; Robert H K Eng, MD

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.